CHEOY OTC
Cochlear Limited
1W: -12.7%
1M: -10.9%
3M: -1.9%
YTD: -50.0%
1Y: -53.0%
3Y: -44.9%
5Y: -43.3%
$43.58
-1.71 (-3.77%)
Weekly Expected Move ±5.9%
$38
$41
$44
$46
$49
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.7B
52W Range31.82-98.49
Volume1,100
Avg Volume64,578
Beta0.26
Dividend$1.45
Analyst Ratings
No analyst coverage
Company Info
CEODiggory William Howitt
Employees5,400
SectorHealthcare
IndustryMedical - Devices
IPO Date2010-04-05
Websitecochlear.com
1 University Avenue
Sydney, NSW 2109
AU
Sydney, NSW 2109
AU
61 2 9428 6555
About Cochlear Limited
Cochlear Limited is a global healthcare company specializing in advanced auditory solutions. It develops and manufactures surgically implanted hearing devices for individuals of all ages, from children to adults, across the world. The company's diverse product range features cochlear implant systems, enhanced sound processor upgrades, bone conduction technology, and a variety of complementary accessories and related items. Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia.
Latest News
Cochlear Shares Plunge 39% After Profit Guidance Cut - GuruFocus
JPMorgan initiates Cochlear stock at neutral on valuation concerns By Investing.com - Investing.com Australia
This World Hearing Day, Cochlear brings the world's first and only smart hearing implant system to India
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
Recent Insider Trades
No insider trades found